PHARMALLIANCE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
PHARMALLIANCE
NACE 47.730, Retail sale of pharmaceutical products
financial year 31-12-2025 compared with 31-12-2024filed annual accounts (NBB)
Net result for the year
€43,298
31-12-2024 · €62,582-€19,284
Equity
€1.2m
31-12-2024 · €1.2m+€43,298
Cash
€68,305
31-12-2024 · €127,884-€59,579
Balance sheet total
€6.4m
31-12-2024 · €6.5m-€102,798
Largest movements
Assets
- Receivables within one year +€155,021
up €155,021 (+25.2%), from €616,349 to €771,370
of which Other amounts receivable: +€166,329
- Current investments -€85,537
down €85,537 (-30.2%), from €282,788 to €197,251
Equity and liabilities
- Debts after one year -€491,348
down €491,348 (-22.4%), from €2.2m to €1.7m
- Other debts +€274,783
up €274,783 (+61.0%), from €450,428 to €725,212
Income statement
- Gross operating margin +€333,034
up €333,034 (+37.6%), from €886,497 to €1.2m
- Staff costs +€211,154
up €211,154 (+36.4%), from €579,702 to €790,856
- Financial charges +€107,135
up €107,135 (+108%), from €99,599 to €206,735
- Depreciation +€57,260
up €57,260 (+41.3%), from €138,728 to €195,987
- Financial income +€24,261
up €24,261 (+85.3%), from €28,434 to €52,695
From the 31-12-2024 result to the 31-12-2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 31-12-2024
€62,582
Gross operating margin
+€333,034
Staff costs
-€211,154
Depreciation
-€57,260
Other operating charges
+€148
Other operating items
-€439
Financial income
+€24,261
Financial charges
-€107,135
Taxes
-€738
Result 31-12-2025
€43,298
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 31-12-2024 and 31-12-2025 balance sheets and the 31-12-2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€389,071
Investment
-€23,569
Financing
-€425,081
Cash 31-12-2024
€127,884
From operations (derived)
+€389,071
Net result for the year
+€43,298
Depreciation
+€195,987
Stocks and contracts
+€27,623
Receivables within one year
-€155,021
Deferred charges and accrued income
-€1,801
Trade debts
+€19,715
Tax, wage and social debts
-€15,513
Other debts
+€274,783
Investment (derived)
-€23,569
Investment in fixed assets (net)
-€109,107
Current investments
+€85,537
Financing
-€425,081
Debts after one year
-€491,348
Current portion of long-term debt
+€50,077
Short-term financial debts
+€16,190
Cash 31-12-2025
€68,305
brings cash intakes cash out
Every line side by side
| Line | Code | 31-12-2024 | 31-12-2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,482,715 | €6,379,917 | -€102,798 | -1.6% |
| Fixed assets | 21/28 | €4,874,090 | €4,787,209 | -€86,881 | -1.8% |
| Intangible fixed assets | 21 | €127,961 | €72,174 | -€55,787 | -43.6% |
| Tangible fixed assets | 22/27 | €1,828,469 | €1,797,375 | -€31,094 | -1.7% |
| Land and buildings | 22 | €1,502,610 | €1,446,898 | -€55,712 | -3.7% |
| Plant, machinery and equipment | 23 | €121,878 | €168,913 | +€47,034 | +38.6% |
| Furniture and vehicles | 24 | €80,922 | €59,540 | -€21,382 | -26.4% |
| Other tangible fixed assets | 26 | €123,058 | €120,224 | -€2,835 | -2.3% |
| Assets under construction and advance payments | 27 | €0 | €1,800 | +€1,800 | |
| Financial fixed assets | 28 | €2,917,660 | €2,917,660 | = | 0.0% |
| Current assets | 29/58 | €1,608,625 | €1,592,708 | -€15,917 | -1.0% |
| Stocks and contracts in progress | 3 | €577,502 | €549,879 | -€27,623 | -4.8% |
| Stocks | 30/36 | €577,502 | €549,879 | -€27,623 | -4.8% |
| Amounts receivable within one year | 40/41 | €616,349 | €771,370 | +€155,021 | +25.2% |
| Trade receivables | 40 | €581,903 | €570,595 | -€11,308 | -1.9% |
| Other amounts receivable | 41 | €34,446 | €200,775 | +€166,329 | +483% |
| Current investments | 50/53 | €282,788 | €197,251 | -€85,537 | -30.2% |
| Cash at bank and in hand | 54/58 | €127,884 | €68,305 | -€59,579 | -46.6% |
| Deferred charges and accrued income | 490/1 | €4,102 | €5,903 | +€1,801 | +43.9% |
| Total equity and liabilities | 10/49 | €6,482,715 | €6,379,917 | -€102,798 | -1.6% |
| Equity | 10/15 | €1,206,386 | €1,249,684 | +€43,298 | +3.6% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Capital | 10 | €61,500 | €61,500 | = | 0.0% |
| Issued capital | 100 | €61,500 | €61,500 | = | 0.0% |
| Reserves | 13 | €24,900 | €83,840 | +€58,940 | +237% |
| Non-distributable reserves | 130/1 | €6,150 | €6,150 | = | 0.0% |
| Legal reserve | 130 | €6,150 | €6,150 | = | 0.0% |
| Tax-exempt reserves | 132 | €18,750 | €77,690 | +€58,940 | +314% |
| Profit (loss) carried forward | 14 | €1,119,986 | €1,104,344 | -€15,642 | -1.4% |
| Amounts payable | 17/49 | €5,276,329 | €5,130,233 | -€146,096 | -2.8% |
| Amounts payable after more than one year | 17 | €2,197,257 | €1,705,908 | -€491,348 | -22.4% |
| Financial debts | 170/4 | €2,197,257 | €1,705,908 | -€491,348 | -22.4% |
| Amounts payable within one year | 42/48 | €3,079,072 | €3,424,325 | +€345,252 | +11.2% |
| Current portion of amounts payable after more than one year | 42 | €471,474 | €521,552 | +€50,077 | +10.6% |
| Financial debts | 43 | €149,237 | €165,427 | +€16,190 | +10.8% |
| Credit institutions | 430/8 | €149,237 | €165,427 | +€16,190 | +10.8% |
| Trade debts | 44 | €1,867,551 | €1,887,265 | +€19,715 | +1.1% |
| Suppliers | 440/4 | €1,867,551 | €1,887,265 | +€19,715 | +1.1% |
| Taxes, remuneration and social security | 45 | €140,382 | €124,868 | -€15,513 | -11.1% |
| Taxes | 450/3 | €28,153 | €4,769 | -€23,385 | -83.1% |
| Remuneration and social security | 454/9 | €112,229 | €120,100 | +€7,871 | +7.0% |
| Other amounts payable | 47/48 | €450,428 | €725,212 | +€274,783 | +61.0% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €579,702 | €790,856 | +€211,154 | +36.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €138,728 | €195,987 | +€57,260 | +41.3% |
| Other operating charges | 640/8 | €1,993 | €1,845 | -€148 | -7.4% |
| Non-recurring operating charges | 66A | €0 | €439 | +€439 | |
| Gross operating margin | 9900 | €886,497 | €1,219,531 | +€333,034 | +37.6% |
| Operating profit (loss) | 9901 | €166,076 | €230,405 | +€64,329 | +38.7% |
| Financial income | 75/76B | €28,434 | €52,695 | +€24,261 | +85.3% |
| Recurring financial income | 75 | €28,434 | €52,695 | +€24,261 | +85.3% |
| Financial charges | 65/66B | €99,599 | €206,735 | +€107,135 | +108% |
| Recurring financial charges | 65 | €99,599 | €206,735 | +€107,135 | +108% |
| Profit (loss) for the period before taxes | 9903 | €94,911 | €76,365 | -€18,546 | -19.5% |
| Income taxes | 67/77 | €32,329 | €33,067 | +€738 | +2.3% |
| Profit (loss) for the period | 9904 | €62,582 | €43,298 | -€19,284 | -30.8% |
| Transfer to tax-exempt reserves | 689 | - | €58,940 | +€58,940 | |
| Profit (loss) for the period to be appropriated | 9905 | €62,582 | -€15,642 | -€78,224 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.